Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Captopril in hospitalized patients with COVID-19 pneumonia
IRCT20140824018915N10Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of captopril in coronavirus pneumonia (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Oxygen saturation rate, Length of hospitalization and 1 more. Started Sep 2021; status: completed.
02
Drugs
captopril
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on IRCT20140824018915N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140824018915N10.